VIA vs. colposcopy for cervical cancer screening
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial compares two tests—VIA and colposcopy—to see which is better at finding early cervical changes that could lead to cancer. If you have certain symptoms like unusual discharge or bleeding, or an abnormal Pap smear, this study may help decide the best screening approach for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 65 years old.
- You have symptoms like unusual discharge, bleeding after sex, or bleeding between periods.
- Your cervix looks unhealthy during a check-up (e.g., redness, easy bleeding, or white patches).
- You have had a Pap smear that showed abnormal cells (dysplasia).
- You are not pregnant and have never had treatment for cervical lesions.
- You can give informed consent and do not have active vaginal bleeding or a prior diagnosis of invasive cervical cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
This trial tests a high-definition endoscopy technique against standard colposcopy to see which better finds cervical and vaginal lesions. It may help diagnose abnormalities earlier.
This trial uses a special magnifying tool (colposcopy) to check the cervix when it looks unhealthy or your Pap smear shows abnormal cells. It helps doctors find problems early.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
This study checks whether an advanced cervical scanning test (LuViva) can better identify people who may have serious precancer or early cancer of the cervix. You may be asked to have the scan around the time you are already scheduled for a colposcopy because your screening results were concerning.
Hear when a new Cervical Intraepithelial Neoplasia (CIN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.